Email

Specialty

Certifications

Clinical Focus

Education

MD, Mount Sinai School of Medicine

Internship, Internal Medicine St. Vincent's Hospital [CLOSED]

Residency, Neurology Mount Sinai Hospital

Fellowship, Neurophysiology Mount Sinai Hospital

Biography

Dr. Robinson-Papp’s interests include neuropathy and the neurologic complications of HIV/AIDS. She is the recipient of a grant from the National Institiute of Neurologic Disorders and Stroke to study HIV-associated neuropathy (K23 NS066789). In addition to her research, Dr. Robinson-Papp performs electromyography (EMG), autonomic testing and evoked potentials to aid in the diagnosis of disorders of the peripheral nervous system. She is board certified in neurology by the American Board of Psychiatry and Neurology and in EMG by the American Board of Electrodiagnostic Medicine.

Dr. Robinson-Papp is also involved in medical education, and oversees the evaluation of inpatients by the NeuroAIDS consult service, and outpatients in the neurology division of the Jack Martin Fund Clinic. Dr. Robinson-Papp plays a key role in the neurophysiology and NeuroAIDS fellowship training programs, and provides training to healthcare providers visiting Mount Sinai through the AIDS Institute and Arthur Ashe scholarship programs. She is a lecturer for the Mount Sinai Institute for NeuroAIDS disparities and the AIDS Education and Training Center (AETC).

Research

New topic

• HIV-associated Neuropathy: Ethnic Disparities and Pathogenesis (K23 NS066789).• Manhattan HIV Brain Bank (www.mhbb.org) is a longitudinal organ donation study examining the neurologic, neuropsychological, psychiatric, and pathological effects of HIV. • CNS HIV Antiretroviral Therapy Effects Research (CHARTER) https://www.charterresource.ucsd.edu/ is a longitudinal study of the neurologic effects of HIV. • A randomized, rater-blinded study to explore the effect of mefloquine in subjects with progressive multifocal leukoencephalopahty (PML).• The Experience of Chronic Pain in Neuropathic Pain and Back Pain: A Focus Group Approach • The effect of diflunisal (IND 68092) on familial amyloidosis: A randomized, double-blind, placebo-controlled, international multi-center trial of diflunisal on neurologic disease progression in 200 familial amyloid subjects.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Robinson-Papp did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.